Marksans Pharma Limited (NSE:MARKSANS)

India · Delayed Price · Currency is INR

167.90

-0.14 (-0.08%)

Apr 2, 2026, 3:30 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals	26.23B	21.77B	18.52B	14.91B	13.76B
Pharmaceuticals Growth	20.46%	17.56%	24.23%	8.33%	21.32%
Total	26.23B	21.77B	18.52B	14.91B	13.76B
Total Growth	20.46%	17.56%	24.23%	8.33%	21.32%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
United States and North America	12.37B	9.18B	7.75B	6.35B	5.86B
United States and North America Growth	34.68%	18.53%	21.98%	8.47%	34.17%
Europe and The United Kingdom	10.30B	9.43B	7.68B	6.09B	5.82B
Europe and The United Kingdom Growth	9.20%	22.85%	26.02%	4.66%	14.12%
Australia and New Zealand	2.53B	2.19B	2.09B	1.80B	1.46B
Australia and New Zealand Growth	15.54%	4.45%	16.51%	22.89%	3.98%
Rest of World	1.04B	974.49M	1.00B	554.80M	623.00M
Rest of World Growth	6.37%	-2.96%	81.00%	-10.95%	32.27%
India	-	-	-	113.79M	-
Total	26.23B	21.77B	18.52B	14.91B	13.76B
Total Growth	20.46%	17.56%	24.23%	8.34%	21.33%

Source: S&P Global Market Intelligence.